Dynamic expression and activity of NF-κB during post-natal mammary gland morphogenesis

Mechanisms of Development

Volumn 97, Issue 1-2, 2000, Pages 149-155

  Brantley, Dana M ^a   Yull, Fiona E ^a   Muraoka, Rebecca S ^a   Hicks, Donna J ^a   Cook, Christopher M ^a   Kerr, Lawrence D ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c Div Allerg Immunol T   (United States)

Author keywords

Apoptosis; Differentiation; Epithelium; I B ; Inv olution; Mammary; NF B; p105; p50; Proliferation; RelA; Transgenic

Indexed keywords

DNA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; LUCIFERASE; PROTEIN P105; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INVOLUTION; LACTATION; MORPHOGENESIS; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMAL; CELL NUCLEUS; CYTOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMAN; MAMMAE; MICE; MICE, INBRED C57BL; MORPHOGENESIS; NF-KAPPA B; PREGNANCY; PROTEIN PRECURSORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION FACTOR, SP1; TUBULIN;

EID: 0342844268     PISSN: 09254773     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4773(00)00405-6     Document Type: Article

References (19)

1. Attar R.M., Caamano J., Carrasco D., Violetta I., Ishikawa H., Ryseck R.-P., Weih F., Bravo R. Genetic approaches to study Rel/NF-κB/IκB function in mice. Cancer Biol. 8:1997;93-101.
2. Baldwin A.S. Jr., Azizkhan J.C., Jensen D.E., Beg A.A., Coodly L.R. Induction of NF-κB DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol. Cell. Biol. 11:1991;4943-4951.
3. Blackwell T.S., Yull F.E., Chen C.-L., Venkatakrishna A., Blackwell T.R., Hicks D.J., Lancaster L.H., Christman J.W., Kerr L.D. Multi-organ NF-κB activation in a transgenic mouse model of systemic inflammation. Am. J. Respir. Crit. Care Med. 2000;2000. In press.
4. Clarkson R.W.E., Watson C.J. NF-κB and apoptosis in mammary epithelial cells. J. Mammary Gland Biol. Neo. 4:1999;165-175.
5. Cogswell P.C., Guttridge D.C., Funkhouser W.K., Baldwin A.S. Jr. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3. Oncogene. 19:2000;1123-1131.
6. Dejardin E., Bonizzi G., Bellahcene A., Castronovo V., Merville M.P., Bours V. Highly-expressed p100/p52 (NFKB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells. Oncogene. 11:1995;1835-1841.
7. Doerre S., Sista P., Sun S.C., Ballard D.W., Greene W.C. The c-rel protooncogene product represses NF-κB p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 90:1993;1023-1027.
8. Ghosh S., May M.J., Kopp E.B. NF-κB and rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260.
9. Grumont R.J., Gerondakis S. The subunit composition of NF-kappa B complexes changes during B-cell development. Cell Growth Differ. 5:1994;1321-1331.
10. Kretzschmar M., Meisterernst M., Scheidereit C., Li G., Roeder R.G. Transcriptional regulation of the HIV-1 promoter by NF-κB in vitro. Genes Dev. 6:1992;761-774.
11. Liu J., Perkins N.D., Schmid R.M., Nabel G.J. Specific NF-κB subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66:1992;3883-3887.
12. Medina D. The mammary gland: a unique organ for the study of development and tumorigenesis. J. Mammary Gland Biol. Neo. 1:1996;5-19.
13. Nakshatri H., Bhat-Nakshatri P., Martin D.A., Goulet R.J. Jr., Sledge G.W. Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell Biol. 17:1997;3629-3639.
14. Nabel G., Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 326:1987;711-713.
15. Pereira D.S., Kushner D.B., Ricciardi R.P., Graham F.L. Testing NF-κB1-p50 antibody specificity using knockout mice. Oncogene. 13:1996;445-446.
16. Sodroski J., Rosen C., Wong-Staal F., Salahuddin S.Z., Popovic M., Arya S., Gallo R.C., Haseltine W.A. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science. 227:1985;171-173.
17. Sovak M.A., Bellas R.E., Kim D.W., Zanieski G.J., Rogers A.E., Traish A.M., Sonenshein G.E. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:1997;2952-2960.
18. Sovak M.A., Arsura M., Zanieski G., Kavanagh K.T., Sonenshein G.E. The inhibitory effects of transforming growth factor β1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-κB/rel expression. Cell Growth Diff. 10:1999;537-544.
19. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:1995;2723-2735.